To date, the search for effective treatments for dementia has yielded only disappointments. Many recent drug candidates target the tau protein, which aggregates and forms tangles in patients’ brain tissue and is involved in 75% of all dementias. While tau-targeting drugs have looked promising in mouse models, they’ve failed in clinical trials.